Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AZTR is expected to report earnings to rise 184.00% to -70 cents per share on August 17
Q2'26
Est.
$-0.71
Q1'26
Beat
by $0.77
Q4'25
Beat
by $1.37
Q3'25
Missed
by $0.46
Q4'24
Beat
by $0.20
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -101 cents. With 3.43M shares outstanding, the current market capitalization sits at 3.72M.